Further Increase in Quarterly Payments for pharmaceutical sourcing venture if certain milestones are achieved.

No definition available.

Name:	cah_FurtherIncreaseinQuarterlyPayments
Namespace Prefix:	cah_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Increase in Quarterly Payments for pharmaceutical sourcing venture due to the achievement of a milestone.

+ References

No definition available.

+ Details

Name:	cah_IncreaseinQuarterlyPayments
Namespace Prefix:	cah_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Initial term of Pharmaceutical Sourcing Venture

+ References

No definition available.

+ Details

Name:	cah_InitialtermofPharmaceuticalSourcingVenture
Namespace Prefix:	cah_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Maximum Quarterly Payment for pharmaceutical sourcing venture if certain milestones are achieved.

+ References

No definition available.

+ Details

Name:	cah_MaximumQuarterlyPayment
Namespace Prefix:	cah_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number Of Quarterly Payments related to pharmaceutical sourcing venture.

+ References

No definition available.

+ Details

Name:	cah_NumberOfQuarterlyPayments
Namespace Prefix:	cah_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Quarterly payment that we are required to pay related to the pharmaceutical sourcing venture.

+ References

No definition available.

+ Details

Name:	cah_QuarterlyPayments
Namespace Prefix:	cah_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_LitigationReserve
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- References

No definition available.

+ Details

Name:	us-gaap_OtherCommitmentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name:	us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Cash received for the settlement of litigation during the current period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name:	us-gaap_ProceedsFromLegalSettlements
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_LitigationCaseAxis=cah_DEAInvestigationandRelatedMattersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MajorCustomersAxis=cah_CVSHealthMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=cah_OneYearAfterCurrentFiscalYearMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments, Contingent Liabilities and Litigation (Narrative) (Details) $ in Millions	3 Months Ended	6 Months Ended
	Dec. 31, 2015 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Jun. 30, 2015 USD ($)
Loss Contingencies
Proceeds from Legal Settlements	$ 13.0	$ 13.0
Commitments [Abstract]
Payments to Acquire Businesses, Net of Cash Acquired		3,284.0	$ 86.0
DEA Investigation and Related Matters
Loss Contingencies
Litigation accrual	$ 44.0	$ 44.0		$ 41.0
CVS Health
Commitments [Abstract]
Initial term of Pharmaceutical Sourcing Venture		10 years
Number of quarterly payments		39
Quarterly payment		$ 25.6
Increase in quarterly payments		10.0
Fiscal 2017 \| CVS Health
Commitments [Abstract]
Further Increase in Quarterly Payments		10.0
Maximum Quarterly Payment		$ 45.6